Comments

Entero Therapeutics

ENTONASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.00
0.011.12%
At Close: -
$1.02
0.021.89%
After Hours: Jul 19, 5:48 PM EDT
15 minutes delayed

Entero Therapeutics (ENTO) Forecast

NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary

Entero Therapeutics Stock (NASDAQ: ENTO) stock price, news, charts, stock research, profile.

Open$1.00
Close$1.00
Volume / Avg.22.70K / 88.03K
Day Range0.97 - 1.04
52 Wk Range0.92 - 3.16
Market Cap$2.90M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
30
Short Interest
3.61%
Days to Cover1

Recent News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About Entero Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the developmen...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ENTO
ALZN

FAQ

Q

How do I buy Entero Therapeutics (ENTO) stock?

A

You can purchase shares of Entero Therapeutics (NASDAQ:ENTO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Entero Therapeutics (ENTO) competitors?

A

Other companies in Entero Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

Q

What is the target price for Entero Therapeutics (ENTO) stock?

A

There is no analysis for Entero Therapeutics.

Q

What is the forecast for Entero Therapeutics (ENTO) stock?

A

There is no analysis for Entero Therapeutics to provide a consensus price target.

Q

Current stock price for Entero Therapeutics (ENTO)?

A

The stock price for Entero Therapeutics (NASDAQ: ENTO) is $1.02 last updated July 19, 2024 at 5:48 PM EDT.

Q

Does Entero Therapeutics (ENTO) pay a dividend?

A

There are no upcoming dividends for Entero Therapeutics.

Q

When is Entero Therapeutics (NASDAQ:ENTO) reporting earnings?

A

Entero Therapeutics’s Q2 earnings are confirmed for Tuesday, August 20, 2024.

Q

Is Entero Therapeutics (ENTO) going to split?

A

There is no upcoming split for Entero Therapeutics.

Q

What sector and industry does Entero Therapeutics (ENTO) operate in?

A

Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch